Knowstox

Fundamentals snapshot

NRC Health

NRC · NMS · Healthcare · Health Information Services

Current price

$20.42

52-week range

$11.01 - $23.68

Market cap

$451.68M

One-glance verdict

Within fair range

$26.65 our estimate vs market $20.42

Wall Street consensus: $26.00 (-2.4% lower than our fair-value estimate)

Balance sheet

Distressed

4.74x Stretched

Net debt $87.12M. Interest coverage shows how many times profit covers the interest bill.

What this company does

NRC Health

NRC Health sells software and data services to hospitals to help them understand what patients and employees think about the care they provide. The company makes most of its money from subscriptions for these tools, which creates predictable recurring revenue (income that is expected to continue regularly). This matters because hospitals are increasingly focused on patient satisfaction, which can affect their reputation and funding.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $7.83M FY2024 Q4 $1.94M FY2025 Q1 $3.66M FY2025 Q2 $-4.15M FY2025 Q3 $10.18M FY2025 Q4 $6.06M FY2026 Q1 $5.35M FY2026 Q2 $62.00K
Revenue $35.39M
Net income $-3.28M
Diluted EPS -0.15
Operating cash flow $1.39M
Free cash flow $62.00K
Revenue $34.80M
Net income $3.22M
Diluted EPS 0.14
Operating cash flow $7.18M
Free cash flow $5.35M
Revenue $35.19M
Net income —
Diluted EPS 49.58
Operating cash flow $7.18M
Free cash flow $6.06M
Revenue $34.61M
Net income —
Diluted EPS 0.18
Operating cash flow $13.76M
Free cash flow $10.18M
Revenue $34.04M
Net income $-106.00K
Diluted EPS -0.01
Operating cash flow $-1.14M
Free cash flow $-4.15M
Revenue $33.55M
Net income $5.79M
Diluted EPS 0.25
Operating cash flow $6.65M
Free cash flow $3.66M
Revenue $36.91M
Net income —
Diluted EPS 0.27
Operating cash flow $6.38M
Free cash flow $1.94M
Revenue $35.82M
Net income —
Diluted EPS 0.24
Operating cash flow $9.42M
Free cash flow $7.83M

Is it cheap or expensive?

Fair value $26.65 vs current price $20.42

Wall Street consensus is the average analyst price target: $26.00 (-2.4% lower than our fair-value estimate).

Our most-likely fair value is $26.65 a share — about 30.5% away from today's price of $20.42, so the stock currently looks fairly priced.

fair

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 8.0% · Discount 7.2% · Terminal 2.5%

$26.65

Bear

Growth 2.5% · Discount 7.2% · Terminal 2.5%

$18.18

Bull

Growth 15.0% · Discount 7.2% · Terminal 2.5%

$41.74

Is it drowning in debt?

Distressed

Net debt $87.1M. Interest coverage 4.7x.

Net debt $87.12M
Interest coverage 4.74x

NRC Health's profit covers its interest bill about 4.7 times over. which is stronger than most peers shown here and 4 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Distressed
Worse cushion Baseline Better cushion
NRC BASELINE NRC Health

Total debt $90.45M Interest coverage 4.74x This is the baseline the peer rows are being compared against.

Total debt $13.43M Interest coverage 6.06x +28% vs NRC Carries about 1.3x more debt cushion than NRC.

Total debt $67.95M Interest coverage -0.95x -100% vs NRC This peer has almost no interest-payment cushion compared with NRC.

Total debt $970.43M Interest coverage -0.35x -100% vs NRC This peer has almost no interest-payment cushion compared with NRC.

Total debt $51.38M Interest coverage -18.01x -100% vs NRC This peer has almost no interest-payment cushion compared with NRC.

Total debt $167.06M Interest coverage -1.82x -100% vs NRC This peer has almost no interest-payment cushion compared with NRC.

What you should know

The case for and against NRC

3 Rewards 2 Risks

Rewards

  • Revenue grew 1.9% last year.
  • Returns 42.0% on equity, ahead of 83% of its peers.
  • Free cash flow was positive in 10/10 years.

Risks

  • Stock trades 194.6% above its 5-year average P/E.
  • Operating margin compressed from 30.7% to -0.2% over 3 years.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
85.08x
Forward P/E
19.45x
P/B
68.99x
P/S
3.23x
EV/EBITDA
20.20x
PEG ratio
1.32x

Profitability

How much profit each dollar creates

Gross margin
61.7%
Operating margin
-0.2%
Net margin
4.2%
ROE
42.0%
ROA
8.1%

Health

Liquidity and balance-sheet strength

Debt / equity
13.81x
Current ratio
0.65x
Quick ratio
0.49x
Total debt
$90.45M
Total cash
$3.33M

Growth

How the business has been compounding

Revenue TTM
$140.00M
Revenue 5Y CAGR
-1.8%
EPS TTM
0.24
EPS 5Y CAGR
-26.7%

Cash flow

How much cash the business throws off

Operating CF TTM
$29.51M
Free CF TTM
$15.74M
FCF margin
11.2%

Dividend

Shareholder payout

Yield
3.1%
Payout ratio
250.0%
Last ex-div date
2026-09-25